Skip to main content
. 2020 Feb 10;10:2213. doi: 10.1038/s41598-020-59009-z

Figure 4.

Figure 4

ROC-AUC value using CA125, HE4, IL-6, IL-8, RMI score, ROMA alone of the independent validation phase for patients with malignant and non-malignant ovarian masses ROC analysis for all markers alone for the validation phase and associated tables with predicted probability in combination. ROC-receiver operating characteristic, AUC- area under curve, 95% CI- 95% Confidence Interval. Reference line (grey continuous line) is at AUC 0.5).